Article
Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells.
The Annals of thoracic surgery - 1 Aug 2014
Bennett Daine T, Deng Xin-Sheng, Yu Jessica A, Bell Marshall T, Mauchley David C, Meng Xianzhong, Reece T Brett, Fullerton David A, Weyant Michael J
Abstract excerpt
BACKGROUND: Lung cancer stem cells (CSCs) are a subpopulation of cells that drive growth, invasiveness, and resistance to therapy. Inflammatory eicosanoids are critical to maintain this malignant subpopulation. Secretory phospholipase A2 group IIa (sPLA2) is an important mediator of the growth an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
